Related Experiment Video

Updated: Dec 28, 2025

An Intravital Microscopy-Based Approach to Assess Intestinal Permeability and Epithelial Cell Shedding Performance
07:32

An Intravital Microscopy-Based Approach to Assess Intestinal Permeability and Epithelial Cell Shedding Performance

Published on: December 3, 2020

6.3K

Functional study of the gastric mucosal barrier in hepatic cirrhosis

J A Solis-Herruzo, J Pardo-Rueda

    Acta Hepato-Gastroenterologica
    |September 1, 1976
    PubMed

    Insights

    Patients with hepatic cirrhosis show increased back-diffusion of chloride (Cl-) and hydrogen (H+) ions across the gastric wall. This suggests an impaired gastric mucosal barrier in cirrhosis, potentially linked to observed histological changes.

    Area of Science:

    • Gastroenterology
    • Hepatic Cirrhosis Research
    • Gastric Physiology

    Background:

    • Hepatic cirrhosis can lead to systemic complications affecting various organs.
    • The integrity of the gastric mucosal barrier is crucial for maintaining gastric health.
    • Alterations in gastric ionic flux may indicate mucosal damage.

    Purpose of the Study:

    • To investigate the net ionic flux across the gastric wall in patients with hepatic cirrhosis.
    • To compare ionic flux in cirrhotic patients with healthy controls.
    • To correlate ionic flux findings with histological examination of the gastric mucosa.

    Main Methods:

    • Measurement of net ionic flux (Cl-, H+, Na+) through the gastric wall.
    • Comparison between eleven patients with hepatic cirrhosis and five normal controls.
    • Gastric biopsy for histological assessment of mucosal integrity.

    Main Results:

    • Significantly increased back-diffusion of chloride (Cl-) and hydrogen (H+) ions in the cirrhotic group.
    • Nine out of eleven cirrhotic patients exhibited H+ loss exceeding normal limits.
    • Histological findings included vasodilatation, edema, mucosal hemorrhage, and epithelial desquamation in cirrhotic patients.

    Conclusions:

    • Patients with hepatic cirrhosis demonstrate an elevated loss of H+ and Cl- across the gastric wall.
    • The observed ionic flux abnormalities, coupled with histological evidence of mucosal damage, suggest a compromised gastric mucosal barrier in hepatic cirrhosis.

    More Related Videos

    An In Vivo Method for Evaluating the Gut-Blood Barrier and Liver Metabolism of Microbiota Products14:54

    An In Vivo Method for Evaluating the Gut-Blood Barrier and Liver Metabolism of Microbiota Products

    Published on: October 20, 2018

    8.9K
    Invasive Hemodynamic Characterization of the Portal-hypertensive Syndrome in Cirrhotic Rats09:37

    Invasive Hemodynamic Characterization of the Portal-hypertensive Syndrome in Cirrhotic Rats

    Published on: August 1, 2018

    15.4K

    Related Concept Videos

    Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

    Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

    In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
    130
    Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

    Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

    Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
    168
    Mucosal Barrier of the Stomach01:25

    Mucosal Barrier of the Stomach

    The gastric glands contain parietal cells that secrete hydrochloric acid (HCl) for digestion. The cells secrete HCl because it is highly corrosive and essential for breaking down food. To achieve this, they secrete hydrogen and chloride ions into the lumen of the gastric glands, which combine to form HCl.
    Within parietal cells, carbonic acid is first formed through the reaction of water and carbon dioxide. The dissociation of carbonic acid releases bicarbonate and hydrogen ions. The bicarbonate...
    1.9K
    Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors01:24

    Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors

    Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI)  tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
    1.1K
    Gastritis-II: Pathophysiology01:17

    Gastritis-II: Pathophysiology

    Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
    In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
    In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
    Gastritis can stem from various causes, each...
    1.1K
    Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

    Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

    Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
    Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
    471